All News about Relmada Therapeutics Inc![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Via Benzinga
![]() ![]() ![]()
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via Benzinga
![]() Via Benzinga
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Exposures
COVID-19
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.